Chemfab Alkalis Limited has informed the Exchange about General Updates regarding the reconstitution of the audit, Stakeholders relationship, Nomination and remuneration and also corporate social responsibility committee of the company with effective from the closing hours of 31st July, 2025
CHEMFAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Chemfab Alkalis approved allotment of 4,000 equity shares under its employee stock option scheme (CAESOS 2020) at Rs. 97.83 per share, raising paid-up capital to Rs. 14,36,77,020 (1,43,67,702 shares). The board also amended the CAESOS 2020 scheme to increase the maximum options pool from 4,00,000 to 5,00,000 and revised the exercise pricing to the lower of (market price minus 50%) or Rs. 500 per share, subject to shareholder approval. Non-Executive and Non-Independent Director Mr. C.S. Ramesh resigned for personal reasons, effective close of business on July 31, 2025. Following his exit, the Audit, Stakeholders Relationship, Nomination and Remuneration, and CSR committees have been reconstituted, with Mrs. Drushti Desai chairing most of these committees.
Routine housekeeping update with no material business impact. The small ESOP allotment (4,000 shares) causes negligible dilution, while the director resignation and committee reshuffle are governance formalities. Shareholders should watch for the shareholder approval required for the ESOP scheme amendments.